NeuMoDx Molecular Lands $21,000,000 Series B Funding Round

  • Feed Type
  • Date
    4/2/2014
  • Company Name
    NeuMoDx Molecular
  • Mailing Address
    1250 Eisenhower Place Ann Arbor, MI 48108 USA
  • Company Description
    NeuMoDx Molecular, Inc. will provide hospital and clinical reference laboratories with a vastly superior solution for in vitro molecular diagnostic (MDx) testing.
  • Website
    http://www.neumodx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $21,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    This financing will be used to fund development of the NeuMoDx 500 Molecular IVD System, a fully automated, random access platform capable of performing RNA and DNA-based assays.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

By posting a comment, you agree to our terms and conditions.